MovDisordV3, Main, Exploration, bibRecord, 003E14

Assessing comorbidity in patients with Parkinson's disease

Identifieur interne : 003E14 ( Main/Exploration ); précédent : 003E13; suivant : 003E15

Assessing comorbidity in patients with Parkinson's disease

Auteurs : Martine Visser [Pays-Bas] ; Johan Marinus [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Ruth G. B. Schipper [Pays-Bas] ; Anne M. Stiggelbout [Pays-Bas]

Source :

Movement Disorders [ 0885-3185 ] ; 2004-07.

RBID : ISTEX:C125A7DB8754A89CF74CBCF5F10A93E84B9BAF3B

Descripteurs français

Pascal (Inist)
- Homme, Parkinson maladie, Système nerveux pathologie.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Activities of Daily Living, Aged, Antiparkinson Agents (therapeutic use), Cognition Disorders (diagnosis), Cognition Disorders (epidemiology), Comorbidity, Disability Evaluation, Gastrointestinal Diseases (epidemiology), Human, Humans, Levodopa (therapeutic use), Male, Male Urogenital Diseases (epidemiology), Nervous system diseases, Neuropsychological Tests, Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Parkinson disease, Parkinson's disease, Primary Health Care (statistics & numerical data), Questionnaires, accuracy, comorbidity, disability, interview.
MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- diagnosis : Cognition Disorders.
- drug therapy : Parkinson Disease.
- epidemiology : Cognition Disorders, Gastrointestinal Diseases, Male Urogenital Diseases, Parkinson Disease.
- statistics & numerical data : Primary Health Care.
- Activities of Daily Living, Aged, Comorbidity, Disability Evaluation, Humans, Male, Neuropsychological Tests, Questionnaires.

Abstract

The aim of this study was to assess the accuracy of an interview‐based assessment of comorbidity, in patients with Parkinson's disease (PD). The Cumulative Illness Rating Scale‐Geriatric (CIRS‐G) was completed (1) in an interview with 31 PD patients and their caregivers, and (2) by reviewing the patient's medical charts from their general practitioners. Based on the interview, all patients had some comorbidity, 84% had one or more moderate comorbid diseases. The most frequently affected organ systems were “lower gastrointestinal” and “genitourinary”. The mean ± SD total score of the interview‐based (chart‐based) CIRS‐G was 6.9 ± 3.8 (7.6 ± 3.5) with a mean of 4.3 ± 1.9 (5.0 ± 1.9) affected organ systems and a mean of 2.1 ± 1.7 (2.3 ± 1.6) organ systems with at least moderate comorbidity per patient. The agreement (intraclass correlation coefficients) between the interview‐based and chart‐based assessments for the six summary scores ranged from 0.69 to 0.81. The agreement for the 14 organ systems ranged from 0.13 to 1.00 (weighted kappa); 12 had a Kw above 0.40 (moderate agreement). The comorbidity summary scores had a moderate correlation with age and disability. The interview‐based assessment of the CIRS‐G is easy to apply and is an accurate method to assess comorbidity in patients with PD. © 2004 Movement Disorder Society

Url:

https://api.istex.fr/document/C125A7DB8754A89CF74CBCF5F10A93E84B9BAF3B/fulltext/pdf

DOI: 10.1002/mds.20060

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessing comorbidity in patients with Parkinson's disease</title>
<author><name sortKey="Visser, Martine" sort="Visser, Martine" uniqKey="Visser M" first="Martine" last="Visser">Martine Visser</name>
</author>
<author><name sortKey="Marinus, Johan" sort="Marinus, Johan" uniqKey="Marinus J" first="Johan" last="Marinus">Johan Marinus</name>
</author>
<author><name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
</author>
<author><name sortKey="Schipper, Ruth G B" sort="Schipper, Ruth G B" uniqKey="Schipper R" first="Ruth G. B." last="Schipper">Ruth G. B. Schipper</name>
</author>
<author><name sortKey="Stiggelbout, Anne M" sort="Stiggelbout, Anne M" uniqKey="Stiggelbout A" first="Anne M." last="Stiggelbout">Anne M. Stiggelbout</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C125A7DB8754A89CF74CBCF5F10A93E84B9BAF3B</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20060</idno>
<idno type="url">https://api.istex.fr/document/C125A7DB8754A89CF74CBCF5F10A93E84B9BAF3B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000453</idno>
<idno type="wicri:Area/Istex/Curation">000453</idno>
<idno type="wicri:Area/Istex/Checkpoint">002795</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Visser M:assessing:comorbidity:in</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15254943</idno>
<idno type="wicri:Area/PubMed/Corpus">003409</idno>
<idno type="wicri:Area/PubMed/Curation">003409</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003561</idno>
<idno type="wicri:Area/Ncbi/Merge">000E75</idno>
<idno type="wicri:Area/Ncbi/Curation">000E75</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E75</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Visser M:assessing:comorbidity:in</idno>
<idno type="wicri:Area/Main/Merge">005772</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0455179</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002110</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000C11</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002244</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Visser M:assessing:comorbidity:in</idno>
<idno type="wicri:Area/Main/Merge">005A82</idno>
<idno type="wicri:Area/Main/Curation">003E14</idno>
<idno type="wicri:Area/Main/Exploration">003E14</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Assessing comorbidity in patients with Parkinson's disease</title>
<author><name sortKey="Visser, Martine" sort="Visser, Martine" uniqKey="Visser M" first="Martine" last="Visser">Martine Visser</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology of the Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marinus, Johan" sort="Marinus, Johan" uniqKey="Marinus J" first="Johan" last="Marinus">Johan Marinus</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology of the Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology of the Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schipper, Ruth G B" sort="Schipper, Ruth G B" uniqKey="Schipper R" first="Ruth G. B." last="Schipper">Ruth G. B. Schipper</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology of the Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stiggelbout, Anne M" sort="Stiggelbout, Anne M" uniqKey="Stiggelbout A" first="Anne M." last="Stiggelbout">Anne M. Stiggelbout</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Medical Decision Making, Leiden University Medical Center, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-07">2004-07</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="824">824</biblScope>
<biblScope unit="page" to="828">828</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C125A7DB8754A89CF74CBCF5F10A93E84B9BAF3B</idno>
<idno type="DOI">10.1002/mds.20060</idno>
<idno type="ArticleID">MDS20060</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activities of Daily Living</term>
<term>Aged</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cognition Disorders (diagnosis)</term>
<term>Cognition Disorders (epidemiology)</term>
<term>Comorbidity</term>
<term>Disability Evaluation</term>
<term>Gastrointestinal Diseases (epidemiology)</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Male Urogenital Diseases (epidemiology)</term>
<term>Nervous system diseases</term>
<term>Neuropsychological Tests</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Primary Health Care (statistics & numerical data)</term>
<term>Questionnaires</term>
<term>accuracy</term>
<term>comorbidity</term>
<term>disability</term>
<term>interview</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cognition Disorders</term>
<term>Gastrointestinal Diseases</term>
<term>Male Urogenital Diseases</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Primary Health Care</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Activities of Daily Living</term>
<term>Aged</term>
<term>Comorbidity</term>
<term>Disability Evaluation</term>
<term>Humans</term>
<term>Male</term>
<term>Neuropsychological Tests</term>
<term>Questionnaires</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Parkinson maladie</term>
<term>Système nerveux pathologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The aim of this study was to assess the accuracy of an interview‐based assessment of comorbidity, in patients with Parkinson's disease (PD). The Cumulative Illness Rating Scale‐Geriatric (CIRS‐G) was completed (1) in an interview with 31 PD patients and their caregivers, and (2) by reviewing the patient's medical charts from their general practitioners. Based on the interview, all patients had some comorbidity, 84% had one or more moderate comorbid diseases. The most frequently affected organ systems were “lower gastrointestinal” and “genitourinary”. The mean ± SD total score of the interview‐based (chart‐based) CIRS‐G was 6.9 ± 3.8 (7.6 ± 3.5) with a mean of 4.3 ± 1.9 (5.0 ± 1.9) affected organ systems and a mean of 2.1 ± 1.7 (2.3 ± 1.6) organ systems with at least moderate comorbidity per patient. The agreement (intraclass correlation coefficients) between the interview‐based and chart‐based assessments for the six summary scores ranged from 0.69 to 0.81. The agreement for the 14 organ systems ranged from 0.13 to 1.00 (weighted kappa); 12 had a Kw above 0.40 (moderate agreement). The comorbidity summary scores had a moderate correlation with age and disability. The interview‐based assessment of the CIRS‐G is easy to apply and is an accurate method to assess comorbidity in patients with PD. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Pays-Bas</li>
</country>
<region><li>Hollande-Méridionale</li>
</region>
<settlement><li>Leyde</li>
</settlement>
</list>
<tree><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Visser, Martine" sort="Visser, Martine" uniqKey="Visser M" first="Martine" last="Visser">Martine Visser</name>
</region>
<name sortKey="Marinus, Johan" sort="Marinus, Johan" uniqKey="Marinus J" first="Johan" last="Marinus">Johan Marinus</name>
<name sortKey="Schipper, Ruth G B" sort="Schipper, Ruth G B" uniqKey="Schipper R" first="Ruth G. B." last="Schipper">Ruth G. B. Schipper</name>
<name sortKey="Stiggelbout, Anne M" sort="Stiggelbout, Anne M" uniqKey="Stiggelbout A" first="Anne M." last="Stiggelbout">Anne M. Stiggelbout</name>
<name sortKey="Van Hilten, Jacobus J" sort="Van Hilten, Jacobus J" uniqKey="Van Hilten J" first="Jacobus J." last="Van Hilten">Jacobus J. Van Hilten</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E14 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003E14 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C125A7DB8754A89CF74CBCF5F10A93E84B9BAF3B
   |texte=   Assessing comorbidity in patients with Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Assessing comorbidity in patients with Parkinson's disease

Assessing comorbidity in patients with Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.